These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan 31; 47(1201):12. PubMed ID: 15706700 [Abstract] [Full Text] [Related]
9. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Brannan T, Yahr MD. Ann Neurol; 1995 Jan 31; 37(1):95-8. PubMed ID: 7818264 [Abstract] [Full Text] [Related]
10. Controlled-release carbidopa/levodopa in the treatment of Parkinsonism. Hutton JT, Dippel RL, Bianchine JR, Strahlendorf HK, Meyer PG. Clin Neuropharmacol; 1984 Jan 31; 7(2):135-9. PubMed ID: 6375861 [Abstract] [Full Text] [Related]
11. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Deleu D, Jacques M, Michotte Y, Ebinger G. Neurology; 1989 Nov 31; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654 [Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Lombardo L, De la Garza R. Arch Invest Med (Mex); 1977 Nov 31; 8(2):123-8. PubMed ID: 907417 [Abstract] [Full Text] [Related]
13. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. Londoõ R. Neurol Neurocir Psiquiatr; 1976 Nov 31; 17(4):293-300. PubMed ID: 1018729 [Abstract] [Full Text] [Related]
14. [Clinical experience in switching patients from standard levodopa to a controlled-release levodopa]. Leiva Santana C, Galvañ Berenguer B, Gómez García J, Cabello López J. Neurologia; 1996 Jan 31; 11(1):1-9. PubMed ID: 8714169 [Abstract] [Full Text] [Related]
15. Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease. Rondot P, Ziegler M, Aymard N, Teinturier A. Neurology; 1989 Nov 31; 39(11 Suppl 2):74-7; discussion 95. PubMed ID: 2586765 [Abstract] [Full Text] [Related]
16. Case report: successful use of rectally administered levodopa-carbidopa. Cooper SD, Ismail HA, Frank C. Can Fam Physician; 2001 Jan 31; 47():112-3. PubMed ID: 11212422 [No Abstract] [Full Text] [Related]
17. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio). Stocchi F, Marconi S. Clin Neuropharmacol; 2010 Jul 31; 33(4):198-203. PubMed ID: 20414107 [Abstract] [Full Text] [Related]